Trexquant Investment LP Sutro Biopharma, Inc. Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.29 - $4.9 $270,197 - $402,422	-82,127 Reduced 80.09%	20,421 $70,000
Q2 2023 Aug 11, 2023	SELL	$4.25 - $5.88 $341,343 - $472,258	-80,316 Reduced 43.92%	102,548 $476,000
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $128,387 - $242,160	28,658 Added 18.58%	182,864 $844,000
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $521,183 - $778,402	96,337 Added 166.47%	154,206 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $299,182 - $411,448	57,869 New	57,869 $321,000
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $109,238 - $214,967	-14,041 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $200,084 - $330,384	14,041 New	14,041 $209,000
Q3 2020 Nov 06, 2020	SELL	$7.44 - $13.15 $242,551 - $428,703	-32,601 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.24 - $11.05 $236,031 - $360,241	32,601 New	32,601 $253,000
Q1 2020 May 08, 2020	SELL	$6.19 - $12.16 $63,230 - $124,214	-10,215 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$8.15 - $11.39 $83,252 - $116,348	10,215 New	10,215 $112,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.